These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. vCJD screening and its implications for transfusion--strategies for the future? Turner ML Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S65-8. PubMed ID: 14567540 [TBL] [Abstract][Full Text] [Related]
32. Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation. Armitage WJ; Tullo AB; Ironside JW Eye (Lond); 2009 Oct; 23(10):1926-30. PubMed ID: 19136921 [TBL] [Abstract][Full Text] [Related]
33. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Wroe SJ; Pal S; Siddique D; Hyare H; Macfarlane R; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Hewitt P; Collinge J Lancet; 2006 Dec; 368(9552):2061-7. PubMed ID: 17161728 [TBL] [Abstract][Full Text] [Related]
34. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks. Pozzo di Borgo A; Rochette S; Gaussen A; O'Brien SF; Germain M; Renaud C; Lewin A Transfus Med Rev; 2023 Jul; 37(3):150747. PubMed ID: 37827587 [TBL] [Abstract][Full Text] [Related]
35. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Turner ML; Ironside JW Blood Rev; 1998 Dec; 12(4):255-68. PubMed ID: 9950096 [TBL] [Abstract][Full Text] [Related]
36. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease. Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744 [TBL] [Abstract][Full Text] [Related]
37. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Brandel JP; Peckeu L; Haïk S Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616 [TBL] [Abstract][Full Text] [Related]
38. No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease. Sánchez-Juan P; Bishop MT; Green A; Giannattasio C; Arias-Vasquez A; Poleggi A; Knight RS; van Duijn CM BMC Med Genet; 2007 Dec; 8():77. PubMed ID: 18072964 [TBL] [Abstract][Full Text] [Related]
39. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions. Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123 [TBL] [Abstract][Full Text] [Related]
40. Creutzfeldt-Jakob disease and the risk from blood or blood products. Will RG; Kimberlin RH Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]